Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: The effect of aspirin treatment

被引：32

作者：

H. Makino

M. Mukoyama

A. Sugawara

K. Mori

T. Suganami

K. Yahata

Y. Fujinaga

H. Yokoi

I. Tanaka

K. Nakao

机构：

[1] Department of Medicine, Kyoto Univ. Grad. School of Medicine, Kyoto 606-8507, 54 Shogoin Kawahara-cho, Sakyo-ku

来源：

Clinical and Experimental Nephrology | 2003年 / 7卷 / 1期

关键词：

Connective tissue growth factor; Cyclooxygenase inhibitor; Diabetic nephropathy; Extracellular matrix; Prostanoids; Transforming growth factor-β;

D O I：

10.1007/s101570300004

中图分类号：

学科分类号：

摘要：

Background. Connective tissue growth factor (CTGF) is a cysteine-rich growth factor induced by transforming growth factor-β (TGF-β) and is thought to play a critical role in TGF-β-stimulated extracellular matrix accumulation. To explore its involvement in early diabetic nephropathy, we investigated the time course of CTGF gene expression and its regulation in streptozotocin (STZ)-induced diabetic rat kidney. Methods. Northern blot analysis for CTGF, TGF-β, and fibronectin expression was performed in the glomeruli of STZ-induced diabetic rats from 3 days to 12 weeks after the induction of diabetes, together with histological examination. To investigate the role of prostanoids in this process, aspirin was administered in one group of diabetic rats. Furthermore, CTGF expression was analyzed in rat mesangial cells cultured under high-glucose conditions. Results. Glomerular expression of CTGF and TGF-β1 mRNA was coordinately upregulated as early as day 3, followed by fibronectin induction and mesangial matrix accumulation. Chronic aspirin treatment in diabetic rats significantly attenuated mesangial expansion, and effectively suppressed CTGF induction, as well as inhibiting the upregulation of TGF-β1 and fibronectin expression. In cultured mesangial cells, aspirin treatment abolished high glucose-stimulated CTGF upregulation. Conclusions. These results indicate that CTGF expressed in the glomeruli is upregulated in the early stage of STZ-induced diabetic nephropathy in rats, and could be a critical mediator of the development of diabetic glomerulosclerosis. In addition, the modulatory effects of aspirin during this process suggest a role of the cyclooxygenase pathway in the progression of diabetic nephropathy.

引用

页码：33 / 40

页数：7

共 40 条

[11]

Ryseck R.P., Macdonald-Bravo H., Mattei M.G., Bravo R., Structure, mapping, and expression of fisp-12, a growth factor-inducible Mattei gene encoding a secreted cysteine-rich protein, Cell Growth Differ, 2, pp. 225-233, (1991)

[12]

Bork P., The modular architecture of a new family of growth regulators related to connective tissue growth factor, FEBS Lett, 327, pp. 125-130, (1993)

[13]

Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R., Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair, Mol Biol Cell, 4, pp. 637-645, (1993)

[14]

Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R., Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J Invest Dermatol, 105, pp. 404-411, (1996)

[15]

Ito Y., Aten J., Bende R.J., Oemar B.S., Rabelink T.J., Weening J.J., Et al., Expression of connective tissue growth factor in human renal fibrosis, Kidney Int, 53, pp. 853-861, (1998)

[16]

Murphy M., Godson C., Cannon S., Kato S., Mackenzie H.S., Martin F., Et al., Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells, J Biol Chem, 274, pp. 5830-5834, (1999)

[17]

Riser B.L., Denichilo M., Cortes P., Baker C., Grondin J.M., Yee J., Et al., Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis, J Am Soc Nephrol, 11, pp. 25-38, (2000)

[18]

Gupta S., Clarkson M.R., Duggan J., Brady H.R., Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis, Kidney Int, 58, pp. 1389-1399, (2000)

[19]

Yokoi H., Sugawara A., Mukoyama M., Mori K., Makino H., Suganami T., Et al., Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: A potential target for preventing renal fibrosis, Am J Kidney Dis, 38, (2001)

[20]

Ricupero D.A., Rishikof D.C., Kuang P.P., Poliks C.F., Goldstein R.H., Regulation of connective tissue growth factor expression by prostaglandin E2, Am J Physiol, 275, (1999)

← 1 2 3 4 →